Binding members for IgE molecules

Details for Australian Patent Application No. 2008216008 (hide)

Owner AstraZeneca AB MedImmune Limited

Inventors Cochrane, Duncan; Von-Wachenfeldt, Karin; Dobson, Claire Louise; Eriksson, Per-Olof Fredrik; Cohen, Suzanne; Monk, Phillip David

Agent Davies Collison Cave

Pub. Number AU-B-2008216008

PCT Pub. Number WO2008/099178

Priority 60/901,304 15.02.07 US

Filing date 15 February 2008

Wipo publication date 21 August 2008

Acceptance publication date 5 July 2012

International Classifications

C07K 16/42 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 Drugs for disorders of the respiratory system

A61P 37/08 Drugs for immunological or allergic disorders

C07K 14/705 Peptides having more than 20 amino acids

C07K 16/26 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 Hybrid peptides

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099178 Priority application(s): WO2008/099178

5 July 2012 Application Accepted

  Published as AU-B-2008216008

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216010-Flexible circuit electrode array with wire or film support

2008216004-WNT3A for inhibition of scarring